JP2006001939A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006001939A5 JP2006001939A5 JP2005211965A JP2005211965A JP2006001939A5 JP 2006001939 A5 JP2006001939 A5 JP 2006001939A5 JP 2005211965 A JP2005211965 A JP 2005211965A JP 2005211965 A JP2005211965 A JP 2005211965A JP 2006001939 A5 JP2006001939 A5 JP 2006001939A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5483597P | 1997-08-05 | 1997-08-05 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000506343A Division JP4198315B2 (ja) | 1997-08-05 | 1998-03-20 | Hpv抗原およびストレスタンパク質またはこれらのタンパク質の発現が可能な発現ベクターを含む組成物によって誘起されるhpv抗原に対する免疫応答 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2006001939A JP2006001939A (ja) | 2006-01-05 |
JP2006001939A5 true JP2006001939A5 (ja) | 2006-06-01 |
Family
ID=21993829
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000506343A Expired - Fee Related JP4198315B2 (ja) | 1997-08-05 | 1998-03-20 | Hpv抗原およびストレスタンパク質またはこれらのタンパク質の発現が可能な発現ベクターを含む組成物によって誘起されるhpv抗原に対する免疫応答 |
JP2005211965A Withdrawn JP2006001939A (ja) | 1997-08-05 | 2005-07-21 | Hpv抗原およびストレスタンパク質またはこれらのタンパク質の発現が可能な発現ベクターを含む組成物によって誘起されるhpv抗原に対する免疫応答 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000506343A Expired - Fee Related JP4198315B2 (ja) | 1997-08-05 | 1998-03-20 | Hpv抗原およびストレスタンパク質またはこれらのタンパク質の発現が可能な発現ベクターを含む組成物によって誘起されるhpv抗原に対する免疫応答 |
Country Status (19)
Country | Link |
---|---|
US (4) | US6524825B1 (ja) |
EP (1) | EP1002110B2 (ja) |
JP (2) | JP4198315B2 (ja) |
KR (2) | KR100843109B1 (ja) |
CN (3) | CN100489105C (ja) |
AT (2) | ATE231917T1 (ja) |
AU (1) | AU6492498A (ja) |
BR (1) | BR9812272A (ja) |
CA (1) | CA2298840A1 (ja) |
DE (2) | DE69834671T2 (ja) |
DK (1) | DK1002110T3 (ja) |
ES (2) | ES2191929T3 (ja) |
HK (2) | HK1028981A1 (ja) |
HU (1) | HUP0003601A3 (ja) |
IL (1) | IL134341A0 (ja) |
NZ (3) | NZ538399A (ja) |
PL (1) | PL196805B1 (ja) |
PT (2) | PT1002110E (ja) |
WO (1) | WO1999007860A1 (ja) |
Families Citing this family (75)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1221488A1 (en) | 1993-06-04 | 2002-07-10 | Whitehead Institute For Biomedical Research | Stress proteins and uses therefor |
US7157089B1 (en) | 1996-11-26 | 2007-01-02 | Stressgen Biotechnologies Corporation | Immune responses using compositions containing stress proteins |
ES2191929T3 (es) * | 1997-08-05 | 2003-09-16 | Stressgen Biotechnologies Corp | Respuestas inmunologicas contra los antigenos pvh estimuladas por composiciones que comprenden un antigeno pvh y una proteina de estres o un vector de expresion capaz de expresar dichas proteinas. |
JP2003504074A (ja) | 1999-07-08 | 2003-02-04 | ストレスゲン バイオテクノロジーズ コーポレイション | インビトロでのTh1様応答の誘導 |
US20050226890A1 (en) * | 1999-08-12 | 2005-10-13 | Cohen David I | Tat-based vaccine compositions and methods of making and using same |
AUPQ233799A0 (en) | 1999-08-19 | 1999-09-09 | Minister For Agriculture, Minister For Land And Water Conservation For And On Behalf Of The State Of New South Wales | Recombinant sub-unit vaccine |
US20050100928A1 (en) * | 1999-09-16 | 2005-05-12 | Zycos Inc., A Delaware Corporation | Nucleic acids encoding polyepitope polypeptides |
EP1216055A2 (en) | 1999-09-30 | 2002-06-26 | Corixa Corporation | Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
US7378096B2 (en) | 1999-09-30 | 2008-05-27 | Health Research, Inc. | Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
EP1222289B1 (en) * | 1999-10-20 | 2008-04-16 | The Johns Hopkins University School Of Medicine | Chimeric immunogenic compositions and nucleic acids encoding them |
US8128922B2 (en) | 1999-10-20 | 2012-03-06 | Johns Hopkins University | Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen |
DE60042704D1 (de) * | 2000-01-14 | 2009-09-17 | Whitehead Biomedical Inst | Induktion zytotoxischer lymphozyten durch hitzeschockprotein-fusionsproteine hängt von der atp-bindungsdomäne in hsp ab und is cd4+ unabhängig |
CA2408830A1 (en) * | 2000-05-12 | 2001-11-22 | The Regents Of The University Of California | Treatment of human papillomavirus (hpv)-infected cells |
NZ523408A (en) * | 2000-06-26 | 2006-02-24 | Stressgen Biotechnologies Corp | Human papilloma virus treatment |
AU2001278117A1 (en) * | 2000-08-03 | 2002-02-18 | Johns Hopkins University | Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen |
WO2005090392A1 (en) * | 2004-03-16 | 2005-09-29 | Inist Inc. | Tat-based tolerogen compositions and methods of making and using same |
CN100400099C (zh) * | 2001-01-04 | 2008-07-09 | 北京迪威华宇生物技术有限公司 | 预防和治疗人前列腺癌的重组蛋白疫苗 |
WO2002061113A2 (en) * | 2001-02-01 | 2002-08-08 | The Johns Hopkins University | Nucleic acid derived vaccine that encodes an antigen linked to a polypeptide that promotes antigen presentation |
WO2002062959A2 (en) | 2001-02-05 | 2002-08-15 | Stressgen Biotechnologies Corp. | Hepatitis b virus treatment |
AUPR446801A0 (en) | 2001-04-18 | 2001-05-17 | University Of Queensland, The | Novel compositions and uses therefor |
KR100785397B1 (ko) * | 2001-06-28 | 2007-12-13 | 아피메즈 주식회사 | 인체 파필로마 바이러스 유사 입자를 생산하는 재조합아데노바이러스 벡터 및 자궁경부암 생백신 |
KR100474114B1 (ko) * | 2001-12-24 | 2005-03-08 | 대한민국 | 소 타일레리아병에 대한 면역원성이 증진된 융합단백질, 및 그의 제조방법 및 용도 |
WO2007095318A2 (en) | 2006-02-13 | 2007-08-23 | Fraunhofer Usa, Inc. | Influenza antigens, vaccine compositions, and related methods |
US7763259B2 (en) * | 2003-01-10 | 2010-07-27 | The Regents Of The University Of Colorado | Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection |
US7211257B2 (en) * | 2003-02-10 | 2007-05-01 | Rosalind Franklin University Of Medicine And Science | Methods for inducing apoptosis in ovarian carcinoma cells using an anti-regeneration and tolerance factor antibody |
WO2004098526A2 (en) | 2003-05-05 | 2004-11-18 | Johns Hopkins University | Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein |
EP1664322B1 (en) | 2003-05-22 | 2013-07-10 | Fraunhofer USA, Inc. | Recombinant carrier molecule for expression, delivery and purification of target polypeptides |
EP2289547B1 (en) | 2003-09-12 | 2015-12-16 | Agenus Inc. | Vaccine for treatment and prevention of herpes simplex virus infection |
US7304139B2 (en) * | 2003-10-28 | 2007-12-04 | University Of Florida Research Foundation, Inc. | Polynucleotides and polypeptides of Anaplasma phagocytophilum and methods of using the same |
US20050208482A1 (en) * | 2004-03-16 | 2005-09-22 | Cohen David I | Tat-based immunomodulatory compositions and methods for their discovery and use |
FR2868781B1 (fr) * | 2004-04-13 | 2008-02-22 | Immutep | Composition de vaccin comprenant un ligand cmh de classe ii couple a un antigene, procede de preparation et utilisations |
CN1727362B (zh) * | 2004-07-30 | 2010-12-01 | 中国人民解放军第二军医大学 | 癌胚抗原阳性肿瘤治疗性疫苗的制备及应用 |
CN1769298B (zh) * | 2004-11-05 | 2010-04-07 | 中国人民解放军军事医学科学院生物工程研究所 | 一种具有抗肿瘤作用的融合蛋白及其编码基因与应用 |
WO2006073970A2 (en) | 2005-01-06 | 2006-07-13 | The Johns Hopkins University | Rna interference that blocks expression of pro-apoptotic proteins potentiates immunity induced by dna and transfected dendritic cell vaccines |
CN1299769C (zh) * | 2005-01-31 | 2007-02-14 | 中国医学科学院肿瘤医院肿瘤研究所 | 人乳头瘤病毒和热休克蛋白重组蛋白疫苗及其用途 |
CA2609927A1 (en) * | 2005-04-27 | 2006-11-02 | Leiden University Medical Center | Methods and means for the treatment of hpv induced intraepithelial neoplasias |
US8962278B2 (en) | 2005-08-03 | 2015-02-24 | Ibio Inc. | Compositions and methods for production of immunoglobulins |
US9216212B2 (en) | 2005-08-05 | 2015-12-22 | University Of Massachusetts | Virus-like particles as vaccines for paramyxovirus |
US7951384B2 (en) * | 2005-08-05 | 2011-05-31 | University Of Massachusetts | Virus-like particles as vaccines for paramyxovirus |
WO2007038083A2 (en) * | 2005-09-21 | 2007-04-05 | New York University | Heat shock proteins from mycobacterium leprae and uses thereof |
US7972776B2 (en) * | 2005-11-15 | 2011-07-05 | Oncohealth Corporation | Protein chips for HPV detection |
US7732166B2 (en) * | 2005-11-15 | 2010-06-08 | Oncohealth Corporation | Detection method for human pappilomavirus (HPV) and its application in cervical cancer |
US8277816B2 (en) * | 2006-02-13 | 2012-10-02 | Fraunhofer Usa, Inc. | Bacillus anthracis antigens, vaccine compositions, and related methods |
EP1984388B1 (en) * | 2006-02-13 | 2016-07-06 | iBio, Inc. | Hpv antigens, vaccine compositions, and related methods |
BRPI0712729A2 (pt) * | 2006-05-31 | 2013-07-02 | Nventa Biopharmaceuticals Corp | composiÇÕes hspe7 bioativas purificadas |
CN100410382C (zh) * | 2006-08-18 | 2008-08-13 | 上海交通大学医学院 | 一种可诱生细胞免疫应答的共表达载体和真核表达载体 |
US8968995B2 (en) * | 2008-11-12 | 2015-03-03 | Oncohealth Corp. | Detection, screening, and diagnosis of HPV-associated cancers |
US20100003704A1 (en) * | 2008-06-13 | 2010-01-07 | Shuling Cheng | IN SITU detection of early stages and late stages HPV infection |
AU2007353773A1 (en) * | 2006-12-22 | 2008-11-27 | Dow Agrosciences Llc | Plant-made West Nile virus (WNV) vaccines, vectors and plant codon optimized sequences |
US9085638B2 (en) | 2007-03-07 | 2015-07-21 | The Johns Hopkins University | DNA vaccine enhancement with MHC class II activators |
WO2008124483A1 (en) * | 2007-04-04 | 2008-10-16 | Specigen, Inc. | Protein cage immunotherapeutics |
CA2685558A1 (en) * | 2007-04-28 | 2008-11-06 | Fraunhofer Usa, Inc. | Trypanosoma antigens, vaccine compositions, and related methods |
US8088392B2 (en) * | 2007-06-18 | 2012-01-03 | Yunxu Cao | Capsid proteins and uses therefore |
CN101952320B (zh) * | 2007-06-18 | 2013-08-14 | 上海泽润安珂生物制药有限公司 | 具有免疫原性的物质 |
US8404252B2 (en) | 2007-07-11 | 2013-03-26 | Fraunhofer Usa, Inc. | Yersinia pestis antigens, vaccine compositions, and related methods |
CU23674A1 (es) | 2007-07-31 | 2011-05-27 | Ct Ingenieria Genetica Biotech | Péptidos penetradores a células fusionados a una biomolécula con acción terapéutica |
WO2009026397A2 (en) * | 2007-08-20 | 2009-02-26 | Fraunhofer Usa, Inc. | Prophylactic and therapeutic influenza vaccines, antigens, compositions, and methods |
WO2009127988A1 (en) * | 2008-04-16 | 2009-10-22 | Universite De Lausanne | Method and vaccine for optimizing the specific immune responses |
WO2009129502A2 (en) | 2008-04-18 | 2009-10-22 | The General Hospital Corporation | Immunotherapies employing self-assembling vaccines |
WO2010037046A1 (en) | 2008-09-28 | 2010-04-01 | Fraunhofer Usa, Inc. | Humanized neuraminidase antibody and methods of use thereof |
US8580270B2 (en) * | 2008-09-30 | 2013-11-12 | University Of Massachusetts | Respiratory synctial virus (RSV) sequences for protein expression and vaccines |
CN102405057B (zh) | 2009-03-23 | 2016-05-25 | 那尼尔科斯治疗公司 | 用免疫刺激性Hiv Tat衍生物多肽治疗癌症 |
JP2012526286A (ja) | 2009-05-07 | 2012-10-25 | オンコヘルス コーポレーション | ヒトパピローマウイルス(hpv)およびhpv関連癌の初期段階および後期段階の検出、スクリーニング、および診断のための高度または≧cin2の同定 |
US8784819B2 (en) | 2009-09-29 | 2014-07-22 | Ibio Inc. | Influenza hemagglutinin antibodies, compositions and related methods |
WO2011084598A1 (en) | 2010-01-08 | 2011-07-14 | Oncohealth Corporation | High throughput cell-based hpv immunoassays for diagnosis and screening of hpv-associated cancers |
WO2011115688A2 (en) | 2010-03-19 | 2011-09-22 | H. Lee Moffitt Cancer Center & Research Institute | Integrin interaction inhibitors for the treatment of cancer |
US20140155469A1 (en) | 2011-04-19 | 2014-06-05 | The Research Foundation Of State University Of New York | Adeno-associated-virus rep sequences, vectors and viruses |
EP2734231A1 (en) * | 2011-07-21 | 2014-05-28 | Biotech Tools S.A. | Dosage of dnak |
US9993534B2 (en) | 2013-03-12 | 2018-06-12 | Wisconsin Alumni Research Foundation | Method of treating fungal infection |
RU2537233C2 (ru) * | 2013-03-26 | 2014-12-27 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Кабардино-Балкарский государственный университет им. Х.М. Бербекова" (КБГУ) | Применение комплекса антиоксидантных витаминов и аминокислот в качестве дополнения к стандартным методам терапии и способ лечения папилломавирус-ассоциированных предраковых заболеваний шейки матки и профилактики канцерогенеза при папилломавирусной инфекции |
US9663556B2 (en) | 2013-10-04 | 2017-05-30 | Pin Pharma, Inc. | Treatment of cancers with immunostimulatory HIV tat derivative polypeptides |
FR3011850B1 (fr) * | 2013-10-15 | 2018-04-06 | Cfl Biotech | Vaccin therapeutique contre le cancer a base de proteines de stress rendues immunogenes |
RU2017132190A (ru) * | 2015-03-18 | 2019-04-18 | Омнисайт | Гибридные белки, содержащие модифицированные поверхностные гликопротеины альфавируса и опухолеассоциированный антиген, и способы, связанные с ними |
WO2017015504A1 (en) | 2015-07-21 | 2017-01-26 | Scheibel Steven Frederick | Treatment and prevention of anal conditions |
CN108484776B (zh) * | 2018-03-19 | 2019-11-05 | 首都医科大学附属北京朝阳医院 | 一种融合蛋白、制备方法及其应用 |
Family Cites Families (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US550405A (en) * | 1895-11-26 | Island | ||
GB8404280D0 (en) | 1984-02-17 | 1984-03-21 | Stanford J L | Biological preparations |
IL71683A0 (en) | 1984-04-27 | 1984-09-30 | Yeda Res & Dev | Pharmaceutical compositions for treating arthritis type diseases comprising fractions obtained from mycobacteria |
US4906742A (en) | 1986-07-31 | 1990-03-06 | Whitehead Institute For Biomedical Research | Encoding antigens of M. Leprae |
US6007806A (en) | 1986-08-13 | 1999-12-28 | Transgene S.A. | Expression of a tumor-specific antigen by a recombinant vector virus and use thereof in preventive or curative treatment of the corresponding tumor |
NL8701163A (nl) | 1986-09-09 | 1988-04-05 | Nederlanden Staat | Gebruik van een peptide voor de bereiding van preparaten voor het verlichten, het behandelen en de diagnose van autoimmuunziekten, in het bijzonder arthritische toestanden, verbindingen die met dit peptide verwant zijn, alsmede farmaceutische en diagnostische preparaten en testkits. |
EP0345299A1 (en) | 1987-02-02 | 1989-12-13 | Whitehead Institute For Biomedical Research | Mycobacterium tuberculosis genes encoding protein antigens |
US4952395A (en) | 1987-02-26 | 1990-08-28 | Scripps Clinic And Research Foundation | Mycobacterial recombinants and peptides |
US5504005A (en) | 1987-03-02 | 1996-04-02 | Albert Einstein College Of Medicine Of Yeshiva University | Recombinant mycobacterial vaccine |
US4918166A (en) | 1987-04-10 | 1990-04-17 | Oxford Gene Systems Limited | Particulate hybrid HIV antigens |
NL8703107A (nl) | 1987-12-22 | 1989-07-17 | Nederlanden Staat | Polypeptiden en derivaten daarvan, alsmede de toepassing daarvan in farmaceutische en diagnostische preparaten. |
CA1338778C (en) | 1988-06-15 | 1996-12-10 | Richard A. Young | Stress proteins and uses therefor |
US5114844A (en) | 1989-03-14 | 1992-05-19 | Yeda Research And Development Co., Ltd. | Diagnosis and treatment of insulin dependent diabetes mellitus |
EP0478664B1 (en) | 1989-06-19 | 2003-09-17 | Whitehead Institute For Biomedical Research | Vector-mediated genomic insertion and expression of dna in bcg |
GB8919321D0 (en) | 1989-08-25 | 1989-10-11 | Univ London | Treatment of chronic inflammatory conditions |
GB9007194D0 (en) | 1990-03-30 | 1990-05-30 | Wellcome Found | Live vaccines |
US5348945A (en) | 1990-04-06 | 1994-09-20 | Wake Forest University | Method of treatment with hsp70 |
DE69126668T2 (de) | 1990-11-08 | 1997-10-23 | Univ London | Mycobacterium als adjuvans für antigene |
GB9024320D0 (en) | 1990-11-08 | 1990-12-19 | Univ London | Treatment of uveitis |
GB2251186A (en) | 1990-12-04 | 1992-07-01 | Randall Neal Gatz | Polypeptide for use in treatment of autoimmune disease |
IT1262896B (it) | 1992-03-06 | 1996-07-22 | Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini. | |
US5580563A (en) | 1992-05-01 | 1996-12-03 | Tam; James P. | Multiple antigen peptide system having adjuvant properties, vaccines prepared therefrom and methods of use thereof |
GB9211736D0 (en) | 1992-06-03 | 1992-07-15 | Univ Cardiff | Allergic treatment |
US5736146A (en) | 1992-07-30 | 1998-04-07 | Yeda Research And Development Co. Ltd. | Conjugates of poorly immunogenic antigens and synthetic peptide carriers and vaccines comprising them |
IL102687A (en) | 1992-07-30 | 1997-06-10 | Yeda Res & Dev | Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them |
JP2541081B2 (ja) * | 1992-08-28 | 1996-10-09 | 日本電気株式会社 | バイオセンサ及びバイオセンサの製造・使用方法 |
EP1221488A1 (en) | 1993-06-04 | 2002-07-10 | Whitehead Institute For Biomedical Research | Stress proteins and uses therefor |
US5762939A (en) | 1993-09-13 | 1998-06-09 | Mg-Pmc, Llc | Method for producing influenza hemagglutinin multivalent vaccines using baculovirus |
US5750119A (en) | 1994-01-13 | 1998-05-12 | Mount Sinai School Of Medicine Of The City University Of New York | Immunotherapeutic stress protein-peptide complexes against cancer |
US5997873A (en) | 1994-01-13 | 1999-12-07 | Mount Sinai School Of Medicine Of The City University Of New York | Method of preparation of heat shock protein 70-peptide complexes |
US5961979A (en) | 1994-03-16 | 1999-10-05 | Mount Sinai School Of Medicine Of The City University Of New York | Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens |
IL109790A0 (en) * | 1994-05-25 | 1994-08-26 | Yeda Res & Dev | Peptides used as carriers in immunogenic constructs suitable for development of synthetic vaccines |
GB9419979D0 (en) | 1994-10-04 | 1994-11-16 | Medeva Holdings Bv | Vaccine compositions |
AUPN015794A0 (en) * | 1994-12-20 | 1995-01-19 | Csl Limited | Variants of human papilloma virus antigens |
US5955087A (en) * | 1995-02-24 | 1999-09-21 | Cantab Pharmaceuticals Research Limited | Polypeptides useful as immunotherapeutic agents and methods of polypeptide preparation |
CA2229543A1 (en) * | 1995-08-18 | 1997-02-27 | Sloan-Kettering Institute For Cancer Research | Heat shock protein-based vaccines and immunotherapies |
US5837251A (en) | 1995-09-13 | 1998-11-17 | Fordham University | Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases |
US5985270A (en) | 1995-09-13 | 1999-11-16 | Fordham University | Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes |
CA2231998A1 (en) | 1995-09-13 | 1997-03-20 | Fordham University | Therapeutic and prophylactic methods using heat shock proteins |
US5935576A (en) | 1995-09-13 | 1999-08-10 | Fordham University | Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens |
WO1997026910A2 (de) | 1996-01-27 | 1997-07-31 | Max-Delbrück-Centrum für Molekulare Medizin | Tumorimpfstoff für die immuntherapie von malignen tumoren |
US6130087A (en) | 1996-10-07 | 2000-10-10 | Fordham University | Methods for generating cytotoxic T cells in vitro |
DK0941315T3 (da) | 1996-11-26 | 2006-05-15 | Stressgen Biotechnologies Corp | Fusionsproteiner indeholdende stressproteiner til induktion af immunreaktioner |
US6017540A (en) | 1997-02-07 | 2000-01-25 | Fordham University | Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes |
US5830464A (en) | 1997-02-07 | 1998-11-03 | Fordham University | Compositions and methods for the treatment and growth inhibition of cancer using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy |
CA2282426A1 (en) | 1997-02-18 | 1998-08-20 | The Whitehead Institute For Biomedical Research | Use of heat shock proteins to deliver moieties into cells |
ES2191929T3 (es) * | 1997-08-05 | 2003-09-16 | Stressgen Biotechnologies Corp | Respuestas inmunologicas contra los antigenos pvh estimuladas por composiciones que comprenden un antigeno pvh y una proteina de estres o un vector de expresion capaz de expresar dichas proteinas. |
US6007821A (en) | 1997-10-16 | 1999-12-28 | Fordham University | Method and compositions for the treatment of autoimmune disease using heat shock proteins |
US5948646A (en) | 1997-12-11 | 1999-09-07 | Fordham University | Methods for preparation of vaccines against cancer comprising heat shock protein-peptide complexes |
JP2003504074A (ja) * | 1999-07-08 | 2003-02-04 | ストレスゲン バイオテクノロジーズ コーポレイション | インビトロでのTh1様応答の誘導 |
-
1998
- 1998-03-20 ES ES98910557T patent/ES2191929T3/es not_active Expired - Lifetime
- 1998-03-20 PL PL338478A patent/PL196805B1/pl not_active IP Right Cessation
- 1998-03-20 KR KR1020007001231A patent/KR100843109B1/ko not_active IP Right Cessation
- 1998-03-20 IL IL13434198A patent/IL134341A0/xx unknown
- 1998-03-20 AU AU64924/98A patent/AU6492498A/en not_active Abandoned
- 1998-03-20 AT AT98910557T patent/ATE231917T1/de not_active IP Right Cessation
- 1998-03-20 WO PCT/CA1998/000246 patent/WO1999007860A1/en not_active Application Discontinuation
- 1998-03-20 BR BR9812272A patent/BR9812272A/pt not_active Application Discontinuation
- 1998-03-20 NZ NZ538399A patent/NZ538399A/en unknown
- 1998-03-20 CN CNB988091216A patent/CN100489105C/zh not_active Expired - Fee Related
- 1998-03-20 DE DE1998634671 patent/DE69834671T2/de not_active Expired - Lifetime
- 1998-03-20 EP EP19980910557 patent/EP1002110B2/en not_active Expired - Lifetime
- 1998-03-20 PT PT98910557T patent/PT1002110E/pt unknown
- 1998-03-20 ES ES03001726T patent/ES2266652T3/es not_active Expired - Lifetime
- 1998-03-20 DK DK98910557T patent/DK1002110T3/da active
- 1998-03-20 CN CNA2005100624792A patent/CN1680451A/zh active Pending
- 1998-03-20 JP JP2000506343A patent/JP4198315B2/ja not_active Expired - Fee Related
- 1998-03-20 HU HU0003601A patent/HUP0003601A3/hu unknown
- 1998-03-20 AT AT03001726T patent/ATE327259T1/de not_active IP Right Cessation
- 1998-03-20 CA CA 2298840 patent/CA2298840A1/en not_active Abandoned
- 1998-03-20 NZ NZ522653A patent/NZ522653A/en unknown
- 1998-03-20 KR KR1020067019653A patent/KR20060111731A/ko not_active Application Discontinuation
- 1998-03-20 NZ NZ50256898A patent/NZ502568A/xx unknown
- 1998-03-20 CN CNA2006101055473A patent/CN1915425A/zh active Pending
- 1998-03-20 PT PT03001726T patent/PT1336621E/pt unknown
- 1998-03-20 DE DE1998611087 patent/DE69811087T2/de not_active Expired - Lifetime
-
2000
- 2000-02-04 US US09/498,918 patent/US6524825B1/en not_active Expired - Fee Related
- 2000-11-24 HK HK00107543A patent/HK1028981A1/xx not_active IP Right Cessation
-
2002
- 2002-11-07 US US10/289,760 patent/US6900035B2/en not_active Expired - Fee Related
-
2004
- 2004-02-16 HK HK04101103A patent/HK1058367A1/xx not_active IP Right Cessation
- 2004-09-10 US US10/938,695 patent/US7262014B2/en not_active Expired - Fee Related
-
2005
- 2005-07-21 JP JP2005211965A patent/JP2006001939A/ja not_active Withdrawn
-
2007
- 2007-07-26 US US11/828,900 patent/US20080050399A1/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE2012C042I2 (ja) | ||
BRPI0601358B8 (pt) | Aplicador de clipe cirúrgico | |
BRPI0601402B8 (pt) | Aplicador de grampos cirúrgicos | |
JP2006001939A5 (ja) | ||
BR122017004707A2 (ja) | ||
BRPI0609157A8 (ja) | ||
BRPI0608519A2 (ja) | ||
BR122020005056A2 (ja) | ||
AP2140A (ja) | ||
BR122016029989A2 (ja) | ||
BRPI0604219A (ja) | ||
JP2006276808A5 (ja) | ||
BRPI0618215B8 (ja) | ||
BY2237U (ja) | ||
JP2007049971A5 (ja) | ||
CN105122969C (ja) | ||
CN300725994S (zh) | 鞋底 | |
CN300726004S (zh) | 鞋帮 | |
CN300726699S (zh) | 调料瓶套装(d) | |
CN300726698S (zh) | 调料瓶套装(e) | |
CN300725991S (zh) | 鞋帮 | |
CN300725992S (zh) | 鞋底 | |
CN300725993S (zh) | 鞋帮 | |
CN300726697S (zh) | 调料瓶套装(b) | |
CN300725995S (zh) | 鞋帮 |